Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: does it reduce the antitumor therapeutic efficacy?
Shiloni
E
E
Matzner
Y
Y
D000818:Animals; D003907:Dexamethasone / Q000494:pharmacology*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007376:Interleukin-2 / Q000037:antagonists & inhibitors*; D051379:Mice; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D003907:Dexamethasone